Literature DB >> 11731413

Decreased focal adhesion kinase suppresses papilloma formation during experimental mouse skin carcinogenesis.

G W McLean1, K Brown, M I Arbuckle, A W Wyke, T Pikkarainen, E Ruoslahti, M C Frame.   

Abstract

Although focal adhesion kinase (FAK) is elevated in epithelial cancers, it is not known whether FAK expression influences tumor development in vivo. We found that fak +/- heterozygous mice display reduced 7,12-dimethylbenz[a]anthracene-induced papilloma formation that correlates with reduced FAK protein expression in the skin. However, the frequency of malignant conversion of papillomas into carcinomas is indistinguishable in fak +/- mice and their wild-type fak +/+ littermates, most likely because papilloma FAK protein expression is elevated to wild-type levels. We also found that keratinocyte FAK protein expression is important for cellular responses downstream of ras in vitro (monitored by extracellular signal-regulated kinase activation after integrin engagement). Because 7,12-dimethylbenz[a]anthracene induces an activating mutation of H-ras, this provides one possible explanation for suppression of papilloma formation when FAK protein is limiting.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11731413

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  21 in total

Review 1.  Suppression of tumor and metastasis progression through the scaffolding functions of SSeCKS/Gravin/AKAP12.

Authors:  Irwin H Gelman
Journal:  Cancer Metastasis Rev       Date:  2012-12       Impact factor: 9.264

Review 2.  Focal adhesion complex proteins in epidermis and squamous cell carcinoma.

Authors:  Elizabeth K Duperret; Todd W Ridky
Journal:  Cell Cycle       Date:  2013-09-12       Impact factor: 4.534

3.  Carcinogen-induced squamous papillomas and oncogenic progression in the absence of the SSeCKS/AKAP12 metastasis suppressor correlate with FAK upregulation.

Authors:  Shin Akakura; Rene Bouchard; Wiam Bshara; Carl Morrison; Irwin H Gelman
Journal:  Int J Cancer       Date:  2011-04-01       Impact factor: 7.396

4.  Actomyosin-mediated cellular tension drives increased tissue stiffness and β-catenin activation to induce epidermal hyperplasia and tumor growth.

Authors:  Michael S Samuel; Jose I Lopez; Ewan J McGhee; Daniel R Croft; David Strachan; Paul Timpson; June Munro; Ewald Schröder; Jing Zhou; Valerie G Brunton; Nick Barker; Hans Clevers; Owen J Sansom; Kurt I Anderson; Valerie M Weaver; Michael F Olson
Journal:  Cancer Cell       Date:  2011-06-14       Impact factor: 31.743

5.  Loss of integrin α3 prevents skin tumor formation by promoting epidermal turnover and depletion of slow-cycling cells.

Authors:  Norman Sachs; Pablo Secades; Laura van Hulst; Maaike Kreft; Ji-Ying Song; Arnoud Sonnenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-10       Impact factor: 11.205

6.  Focal-adhesion-independent integrin-αv regulation of FAK and c-Myc is necessary for 3D skin formation and tumor invasion.

Authors:  Elizabeth K Duperret; Ankit Dahal; Todd W Ridky
Journal:  J Cell Sci       Date:  2015-09-10       Impact factor: 5.285

7.  Specific deletion of focal adhesion kinase suppresses tumor formation and blocks malignant progression.

Authors:  Gordon W McLean; Noboru H Komiyama; Bryan Serrels; Hidefumi Asano; Louise Reynolds; Francesco Conti; Kairbaan Hodivala-Dilke; Daniel Metzger; Pierre Chambon; Seth G N Grant; Margaret C Frame
Journal:  Genes Dev       Date:  2004-12-15       Impact factor: 11.361

Review 8.  Genes and pathways driving glioblastomas in humans and murine disease models.

Authors:  Adrian Merlo
Journal:  Neurosurg Rev       Date:  2003-05-29       Impact factor: 3.042

9.  Differential requirement for focal adhesion kinase signaling in cancer progression in the transgenic adenocarcinoma of mouse prostate model.

Authors:  Jill K Slack-Davis; E Daniel Hershey; Dan Theodorescu; Henry F Frierson; J Thomas Parsons
Journal:  Mol Cancer Ther       Date:  2009-08-11       Impact factor: 6.261

10.  Osteopontin facilitates ultraviolet B-induced squamous cell carcinoma development.

Authors:  Pi-Ling Chang; Yu-Hua Hsieh; Chao-Cheng Wang; M Margaret Juliana; Yuko Tsuruta; Laura Timares; Craig Elmets; Kang-Jey Ho
Journal:  J Dermatol Sci       Date:  2014-05-21       Impact factor: 4.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.